| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $31.4M | -17.8% | -41.7% |
| SG&A Expense | $9.7M | +14.3% | +58.2% |
| Operating Income | -$41.1M | +12.0% | +31.6% |
| Income Tax | $0 | — | — |
| Net Income | -$36.9M | +14.7% | +34.5% |
| EPS (Basic) | -$0.52 | +21.2% | +54.0% |
| EPS (Diluted) | -$0.52 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $217.6M | +113.8% | +123.7% |
| Current Assets | $599.8M | +78.9% | +124.0% |
| Total Assets | $599.9M | +78.7% | +123.6% |
| Current Liabilities | $23.5M | +6.1% | -24.9% |
| Stockholders' Equity | $576.4M | +83.8% | +143.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$104.5M | — | — |
| Investing Cash Flow | -$286.3M | — | — |
| Financing Cash Flow | $494.3M | — | — |
| +54.0% |